Developed in collaboration with The Michael J. Fox Foundation, this model contains a deletion of the Pink1 (PTEN-induced putative kinase 1) gene, encoding for a serine/threonine protein kinase. Mutations in Pink1 are implicated in early-onset Parkinson’s disease. Pink1 knockout rats show both motor impairments and dopaminergic cell loss, making this a useful model of Parkinson’s disease.
Request a quote and a SAGE® Labs research specialist will contact you with an estimated price and delivery date.
Figure 1. Increased fatigue in Pink1 knockout rats
Pink1 homozygous and heterozygous knockout rats display decreased movement in an open field after hindlimb fatigue challenge, indicative of increased hindlimb fatigue.
Figure 2. Decreased performance on tapered balance beam in Pink1 knockout rats
Pink1 homozygous and heterozygous knockout rats display increased hindlimb foot slips on a tapered balance beam. No differences were seen in forelimb foot slips.
This model is being developed in partner with the Michael J. Fox Foundation as part of our Parkinson's disease research suite. Pink1 protein kinase localizes to the mitochondria and is thought to protect cells from stress-induced mitochondrial dysfunction. Mutations within this gene result in one form of autosomal recessive early-onset Parkinson's.
